Renal Failure (Jan 2020)

Hepatitis C virus and carpal tunnel syndrome in hemodialysis patients: a single center cross-sectional study

  • Ling Yu,
  • Shen Shen,
  • Yuan Zu,
  • Jia Huang,
  • Han Li,
  • Shixiang Wang

DOI
https://doi.org/10.1080/0886022X.2020.1832522
Journal volume & issue
Vol. 42, no. 1
pp. 1076 – 1082

Abstract

Read online

Objectives Carpal tunnel syndrome (CTS) is a common complication in maintenance hemodialysis (MHD) patients and leads to disabilities and increased risk of mortality. Hepatitis C virus (HCV) infection is associated with inflammatory and oxidative stress, and HCV infection can be cured. This study aimed at evaluating the association of HCV infection with CTS. Methods Using a cross-sectional design, anthropometric and laboratory data were collected. Serum β2-microglobulin, HCV antibody and HCV-RNA were measured. CTS was diagnosed according to clinical manifestation, electrophysiological test or ultrasonography. The related factors for CTS were analyzed by multivariate logistic regression. Results This study included 113 participants, of whom 33 (29.2%) patients were positive for HCV antibody and 18 (15.9%) were positive for HCV antibody and HCV-RNA. Thirty-two (28.3%) patients were diagnosed with CTS. There were significant differences in the dialysis vintage, age of onset of MHD, high-sensitivity C-reactive protein, serum β2M, anti-HCV-positive, HCV-RNA-positive, HCV load values and urine volume category between the CTS group and non-CTS group (p < 0.05). High-sensitivity C-reactive protein (OR: 1.238, 95% CI: 1.071–1.431, p = 0.004), dialysis vintage (OR: 1.017, 95% CI: 1.008–1.026, p < 0.001) and HCV-RNA-positive (OR: 5.929, 95% CI: 1.295–27.132, p = 0.022) rather than anti-HCV-positive were related factors for CTS. Conclusions High-sensitivity C-reactive protein, dialysis vintage and HCV-RNA replication but not previous HCV-infection were related factors for CTS in MHD patients. Further studies are needed to clarify whether intervention is beneficial for preventing and delaying the progression of CTS in MHD patients with HCV-RNA replication.

Keywords